vTv Therapeutics Inc.
VTVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,017 | $0 | $2,018 | $4,005 |
| % Growth | – | -100% | -49.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1,017 | $0 | $2,018 | $4,005 |
| % Margin | 100% | – | 100% | 100% |
| R&D Expenses | $11,546 | $13,595 | $12,357 | $13,324 |
| G&A Expenses | $13,651 | $11,907 | $12,201 | $12,343 |
| SG&A Expenses | $13,651 | $11,907 | $12,201 | $12,343 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25,197 | $25,502 | $24,558 | $25,667 |
| Operating Income | -$24,180 | -$25,502 | -$22,540 | -$21,662 |
| % Margin | -2,377.6% | – | -1,116.9% | -540.9% |
| Other Income/Exp. Net | $1,575 | -$464 | -$2,333 | $4,046 |
| Pre-Tax Income | -$22,605 | -$25,966 | -$24,873 | -$17,616 |
| Tax Expense | $100 | $0 | $200 | $115 |
| Net Income | -$18,462 | -$20,250 | -$19,164 | -$12,987 |
| % Margin | -1,815.3% | – | -949.7% | -324.3% |
| EPS | -3.2 | -9.71 | -9.98 | -8.29 |
| % Growth | 67% | 2.7% | -20.4% | – |
| EPS Diluted | -3.2 | -9.71 | -9.98 | -8.29 |
| Weighted Avg Shares Out | 5,771 | 2,085 | 1,920 | 1,566 |
| Weighted Avg Shares Out Dil | 5,771 | 2,085 | 1,920 | 1,566 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,565 | $472 | $352 | $1 |
| Interest Expense | $0 | $13 | $15 | $12 |
| Depreciation & Amortization | $89 | $90 | $92 | $89 |
| EBITDA | -$22,516 | -$25,863 | -$24,766 | -$17,515 |
| % Margin | -2,214% | – | -1,227.3% | -437.3% |